Showing results (51-60 of 1,992) with videos related to
Sort By:
Pageof 200
Endocrine, Metabolic & Immune Disorders Drug Targets|May 30, 2018
Exploring the Possible Prognostic Role of B-Lymphocyte Stimulator (BLyS) in a Large Series of Patients with Neuroendocrine TumorsFranco Grimaldi, Fabio Vescini, Veronica Tonelli, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|October 1, 2019
Our Little Friends with Big Roles: Alterations of the Gut Microbiota in Thyroid DisordersHanieh-Sadat Ejtahed, Pooneh Angoorani, Ahmad-Reza Soroush, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|April 6, 2017
Food Protein Induced Proctocolitis: A Benign Condition with an Obscure Immunologic MechanismSophia Tsabouri, Nicolaos Nicolaou, Konstantinos Douros, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|July 26, 2019
UCP2, SHBG, Leptin, and T3 Levels are Associated with Resting Energy Expenditure in Obese WomenSomaye Ahmadi, Hamideh Pishva, Mohammad R Eshraghian, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|August 2, 2019
Key Relevance of Epigenetic Programming of Adiponectin Gene in Pathogenesis of Metabolic DisordersKaiser Un Nisa, Mohammad Irshad RezaEndocrine, Metabolic & Immune Disorders Drug Targets|March 14, 2019
Inflammatory Bowel Disease Therapies Adversely Affect Fertility in Men- A Systematic Review and Meta-analysisAntara Banerjee, Marco Scarpa, Surajit Pathak, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|March 2, 2019
Dysregulated Interleukin -33/ST2 Pathway Perpetuates Chronic Inflammation in Hashimoto's ThyroiditisXuan Wang, Xiaoqing Shao, Xinhao Liu, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|March 5, 2019
Epigenetic Modifications Associated with the Pathogenesis of Type 2 Diabetes MellitusTareq Hossan, Shoumik Kundu, Sayeda Sadia Alam, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|March 6, 2019
Insights into the Role of DNA Methylation and Protein Misfolding in Diabetes MellitusSara M Ahmed, Dina Johar, Mohamed Medhat Ali, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|March 13, 2019
Sepsis: From Historical Aspects to Novel Vistas. Pathogenic and Therapeutic ConsiderationsThea Magrone, Emilio JirilloPageof 200